特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
963094

創薬における人工知能 (AI) の市場規模・シェア・動向分析:治療領域 (がん・心血管疾患・代謝性疾患) 用途・地域・セグメント別の予測 (2020~2027年)

Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report By Therapeutic Area (Oncology, Cardiovascular Disease, Metabolic Diseases), By Application, By Region, And Segment Forecasts, 2020 - 2027

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 80 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.41円
創薬における人工知能 (AI) の市場規模・シェア・動向分析:治療領域 (がん・心血管疾患・代謝性疾患) 用途・地域・セグメント別の予測 (2020~2027年)
出版日: 2020年09月08日
発行: Grand View Research, Inc.
ページ情報: 英文 80 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の創薬における人工知能 (AI) の市場規模は、2027年までに35億米ドルへ達すると予測されており、予測期間中は28.8%のCAGRで拡大する見込みです。

人工知能 (AI) プラットフォームの採用の拡大は、創薬に関連する全体的なコストを削減し、結果を向上させることで、医薬品市場におけるこれらのプラットフォームの需要を推進することが期待されます。

当レポートでは、世界の創薬における人工知能 (AI) 市場について調査し、市場の概要と動向、各セグメント・地域別の動向分析と市場シェア、競合情勢、および主要企業のプロファイルなどを提供しています。

目次

第1章 調査手法・範囲

第2章 エグゼクティブサマリー

第3章 創薬におけるAI市場の変数、動向、および範囲

  • 市場セグメンテーション
  • 創薬におけるAI市場のダイナミクス
  • 世界の創薬におけるAI市場:PESTLE分析
  • 世界の創薬におけるAI市場:ポーターのファイブフォース分析

第4章 世界の創薬におけるAI市場:用途別の推計&動向分析

  • 創薬における人工知能 (AI) 市場:用途別の動向分析
  • 薬剤の最適化と転用
  • 前臨床試験
  • その他

第5章 世界の創薬におけるAI市場:治療領域別の推計&動向分析

  • 創薬における人工知能 (AI) 市場:治療領域別の動向分析
  • がん
  • 神経変性疾患
  • 循環器疾患
  • 代謝性疾患
  • 感染症
  • その他

第6章 世界の創薬における人工知能 (AI) 市場:地域別の推計&動向分析

  • 世界の創薬における人工知能 (AI) 市場:地域別の動向分析
  • 世界の創薬における人工知能 (AI) 市場シェア:地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • ロシア
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • シンガポール
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第7章 競合分析

  • 最近の動向と影響分析:主要な市場参入企業別
  • 企業/競合の分類(主要なイノベーター、マーケットリーダー、新興企業)
  • 競争力ダッシュボード&企業の市場ポジション分析

第8章 競合情勢

  • IBM Watson
  • Exscientia
  • GNS Healthcare.
  • Alphabet (DeepMind)
  • Benevolent AI
  • BioSymetrics
  • Euretos.
  • Berg Health
  • Atomwise
  • Insitro
  • Cyclica
図表

List of Tables

  • Table 1 Partial list of secondary sources
  • Table 2 North America AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 3 North America AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 4 The U.S. AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 5 The U.S. AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 6 Canada AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 7 Canada AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 8 Europe AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 9 Europe AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 10 The U.K. AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 11 The U.K. AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 12 Germany AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 13 Germany AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 14 France AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 15 France AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 16 Spain AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 17 Spain AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 18 Italy AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 19 Italy AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 20 Russia AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 21 Russia AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 22 Asia Pacific AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 23 Asia Pacific AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 24 China AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 25 China AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 26 India AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 27 India AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 28 Japan AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 29 Japan AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 30 Australia AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 31 Australia AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 32 Singapore AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 33 Singapore AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 34 South Korea AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 35 South Korea AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 36 Latin America AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 37 Latin America AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 38 Brazil AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 39 Brazil AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 40 Mexico AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 41 Mexico AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 42 Argentina AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 43 Argentina AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 44 Middle East & Africa AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 45 Middle East & Africa AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 46 South Africa AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 47 South Africa AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 48 Saudi Arabia AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 49 Saudi Arabia AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
  • Table 50 UAE AI drug discovery market, by application, 2016 - 2027 (USD Million)
  • Table 51 UAE AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Global AI in drug discovery market snapshot, 2019 (USD Million)
  • Fig. 9 Global AI in drug discovery market segmentation
  • Fig. 10 Global AI in drug discovery market dynamics
  • Fig. 11 Global AI in drug discovery market driver impact
  • Fig. 12 Global AI in drug discovery market restraints impact
  • Fig. 13 Global AI in drug discovery market - PESTLE analysis
  • Fig. 14 Global AI in drug discovery market - Porter's Analysis
  • Fig. 15 Global AI in drug discovery market - Application outlook and key takeaways
  • Fig. 16 Global AI in drug discovery market - Application movement analysis
  • Fig. 17 Drug optimization and repurposing market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 18 Preclinical testing market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 19 Others market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 20 Global AI in drug discovery market - Therapeutic area outlook and key takeaways
  • Fig. 21 Global AI in drug discovery market - Therapeutic area movement analysis
  • Fig. 22 Oncology market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 23 Neurodegenerative Diseases market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 24 Cardiovascular Disease market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 25 Metabolic Diseases market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 26 Infectious Disease market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 28 Global AI in drug discovery market - Regional outlook and key takeaways
  • Fig. 29 Global AI in drug discovery market - Regional movement analysis
  • Fig. 30 North America AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 31 The U.S. AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 32 Canada AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 33 Europe AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 34 The U.K. AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 35 Germany AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 36 France AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 37 Spain AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 38 Italy AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 39 Russia AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 40 Asia Pacific AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 41 China AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 42 India AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 43 Japan AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 44 Australia AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 45 Singapore AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 46 South Korea AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 47 Latin America AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 48 Brazil AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 49 Mexico AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 50 Argentina AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 51 Middle East & Africa AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 52 South Africa AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 53 Saudi Arabia AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 54 UAE AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 55 Recent Developments & Impact Analysis, By Key Market Participants
  • Fig. 56 Company market position analysis, 2019
  • Fig. 57 Strategic alliance and deals analysis
目次
Product Code: GVR-4-68039-029-7

Artificial Intelligence In Drug Discovery Market Growth & Trends

The global artificial intelligence in drug discovery market size is expected to reach USD 3.5 billion by 2027, expanding at a CAGR of 28.8%, according to a new report by Grand View Research, Inc. The growing adoption of artificial intelligence (AI) platforms aimed at reducing the overall cost associated with drug discovery and to enhance results is expected to propel the demand for these platforms in the pharma market.

Based on the application, the drug optimization and repurposing segment accounted for the largest revenue share in 2019. AI platforms help in identifying alternative applications for existing medicines. This can help pharma companies diversify their portfolio of offerings and assist in producing alternative therapies through minor alterations in the pharmaceutical product. Furthermore, AI platforms also enable researchers to identify the toxic effects of the medicine on the body and thus reduce the chances of adverse effects.

In 2019, oncology application accounted for the largest share whereas, the infectious disease application segment is expected to emerge as the fastest-growing application segment over the forecast period. Artificial intelligence already plays a vital role in the early detection of cancer. Furthermore, as treatments for cancer may vary for each patient, personalized medicine has proven to be an effective alternative.

North America dominated the market with a revenue share of 59.4% in 2019 owing to the increasing adoption of artificial intelligence and the presence of a large number of market players. Asia Pacific is expected to emerge as the fastest-growing region in the market over the forecast period. The growing adoption of new technology in India and China for new drug development and a focus towards boosting pharmaceutical capacities within the countries is expected to drive the market in the region.

Artificial Intelligence In Drug Discovery Market Report Highlights

The drug optimization and repurposing segment accounted for the largest revenue share of 54.4% in 2019

By therapeutic area, the oncology segment was valued at USD 125.0 million in 2019

By therapeutic area, the infectious disease segment is expected to witness the fastest growth of 31.4% from 2020 to 2027

In Asia Pacific, the AI in drug discovery market is expected to witness a CAGR of 32.1% from 2020 to 2027

North America and Europe together accounted for 78.6% share of the market revenue in 2019.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
    • 1.1.1 Information Procurement
  • 1.2 Information or Data Analysis
  • 1.3 Market Formulation & Validation
  • 1.4 Segment Share Calculation
  • 1.5 List of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Global AI in Drug Discovery Market Variables, Trends & Scope

  • 3.1 Market Segmentation
  • 3.2 AI in Drug Discovery Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraint Analysis
  • 3.3 Global AI in Drug Discovery Market: Pestle Analysis
  • 3.4 Global AI in Drug Discovery Market: Porter's Analysis

Chapter 4 Global AI in Drug Discovery Market: Application Estimates &Trend Analysis

  • 4.1 AI in Drug Discovery Market: Application Movement Analysis
  • 4.2 Drug Optimisation and Repurposing
    • 4.2.1 Drug Optimisation and Repurposing Market Estimates And Forecasts, 2016 - 2027 (USD Million)
  • 4.3 Preclinical Testing
    • 4.3.1 Preclinical Testing Market Estimates And Forecasts, 2016 - 2027 (USD Million)
  • 4.4 Others
      • 4.4.1Others Market Estimates And Forecasts, 2016 - 2027 (USD Million)

Chapter 5 Global AI in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1 AI in Drug Discovery Market: Therapeutic Area Movement Analysis
  • 5.2 Oncology
    • 5.2.1 Oncology Market Estimates And Forecasts, 2016 - 2027 (USD Million)
  • 5.3 Neurodegenerative Diseases
    • 5.3.1 Neurodegenerative Diseases Market Estimates And Forecasts, 2016 - 2027 (USD Million)
  • 5.4 Cardiovascular Disease
    • 5.4.1 Cardiovascular Disease Market Estimates And Forecasts, 2016 - 2027 (USD Million)
  • 5.5 Metabolic Diseases
    • 5.5.1 Metabolic Diseases Market Estimates And Forecasts, 2016 - 2027 (USD Million)
  • 5.6 Infectious Disease
    • 5.6.1 Infectious Disease Market Estimates And Forecasts, 2016 - 2027 (USD Million)
  • 5.7 Others
    • 5.7.1 Others Market Estimates And Forecasts, 2016 - 2027 (USD Million)

Chapter 6 Global AI in Drug Discovery Market: Regional Estimates & Trend Analysis

  • 6.1 Global AI in Drug Discovery Market Movement Analysis, By region
  • 6.2 Global AI in Drug Discovery Market Share, By Region, 2019 & 2027
  • 6.3 North America
    • 6.3.1 North America AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.3.2 The U.S.
      • 6.3.2.1 The U.S. AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.3.3 Canada
      • 6.3.3.1 Canada AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
  • 6.4 Europe
    • 6.4.1 Europe AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.4.2 The U.K.
      • 6.4.2.1 U.K. AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.4.3 Germany
      • 6.4.3.1 Germany AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.4.4 France
      • 6.4.4.1 France AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.4.5 Spain
      • 6.4.5.1 Spain AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.4.6 Italy
      • 6.4.6.1 Italy AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.4.7 Russia
      • 6.4.7.1 Russia AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
  • 6.5 Asia Pacific
    • 6.5.1 Asia Pacific AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.5.2 China
      • 6.5.2.1 China AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.5.3 India
      • 6.5.3.1 India AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.5.4 Japan
      • 6.5.4.1 Japan AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.5.5 Australia
      • 6.5.5.1 Australia AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.5.6 Singapore
      • 6.5.6.1 Singapore AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.5.7 South Korea
      • 6.5.7.1 South Korea AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
  • 6.6 Latin America
    • 6.6.1 Latin America AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.6.2 Brazil
      • 6.6.2.1 Brazil AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.6.3 Mexico
      • 6.6.3.1 Mexico AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.6.4 Argentina
      • 6.6.4.1 Argentina AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
  • 6.7 MEA
    • 6.7.1 MEA AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.7.2 South Africa
      • 6.7.2.1 South Africa AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.7.3 Saudi Arabia
      • 6.6.3.1 Saudi Arabia AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 6.7.4 UAE
      • 6.7.4.1 UAE AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2027 (USD Million)

Chapter 7 Competitive Analysis

  • 7.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
  • 7.3. Competitive Dashboard & Company Market Position Analysis
      • 7.3.1Synergy Analysis: Major Deals & Strategic Alliances
      • 7.3.2List Of Key Emerging Companies /TechnologyDisruptors/Innovators

Chapter 8 Competitive Landscape

  • 8.1 IBM Watson
    • 8.1.1 Company Overview
    • 8.1.2 Financial Performance
    • 8.1.3 Offerings
    • 8.1.4 Strategic Initiatives
  • 8.2 Exscientia
    • 8.2.1 Company Overview
    • 8.2.2 Financial Performance
    • 8.2.3 Offerings
    • 8.2.4 Strategic Initiatives
  • 8.3 GNS Healthcare.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Performance
    • 8.3.3 Offerings
    • 8.3.4 Strategic Initiatives
  • 8.4 Alphabet (DeepMind)
    • 8.4.1 Company Overview
    • 8.4.2 Financial Performance
    • 8.4.3 Offerings
    • 8.4.4 Strategic Initiatives
  • 8.5 Benevolent AI
    • 8.5.1 Company Overview
    • 8.5.2 Financial Performance
    • 8.5.3 Offerings
    • 8.5.4 Strategic Initiatives
  • 8.6 BioSymetrics
    • 8.6.1 Company Overview
    • 8.6.2 Financial Performance
    • 8.6.3 Offerings
    • 8.6.4 Strategic Initiatives
  • 8.7 Euretos.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Performance
    • 8.7.3 Offerings
    • 8.7.4 Strategic Initiatives
  • 8.8 Berg Health
    • 8.8.1 Company Overview
    • 8.8.2 Financial Performance
    • 8.8.3 Offerings
    • 8.8.4 Strategic Initiatives
  • 8.9 Atomwise
    • 8.9.1 Company Overview
    • 8.9.2 Financial Performance
    • 8.9.3 Offerings
    • 8.9.4 Strategic Initiatives
  • 8.10 Insitro
    • 8.10.1 Company Overview
    • 8.10.2 Financial Performance
    • 8.10.3 Offerings
    • 8.10.4 Strategic Initiatives
  • 8.11 Cyclica
    • 8.11.1 Company Overview
    • 8.11.2 Financial Performance
    • 8.11.3 Offerings
    • 8.11.4 Strategic Initiatives
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.